This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Dear Patient,

This website will provide you with a comprehensive overview of an investigational treatment option for advanced neuroendocrine tumors (NETs) being investigated in the phase III clinical trials COMPETE and COMPOSE. The information outlined on this website does not replace a consultation with your doctor.

If you are interested in participating in one of these research studies, please reach out to your attending physician who will provide you with detailed information and determine whether you meet the eligibility criteria to enter the study.

Sincerely,
Your COMPETE and COMPOSE Teams

Neuroendocrine Tumors

More

COMPETE Trial

More

n.c.a. Lutetium-177-Edotreotide

More

Targeted Radionuclide Therapy

More

COMPOSE Trial

More

Clinical Trials

More